Advance Development of a Cell-Based Test for Screening of Drugs to Correct Circadian Rhythm Defects in PWS

Funding Summary

The purpose of this project is to develop a cellular assay specific to circadian rhythm defects identified by the Reiter laboratory. The eventual goal is to use this assay to screen for compounds that can normalize these circadian defects, potentially identifying drugs that would address developmental and metabolic changes that accompany circadian rhythm defects in Prader-Willi (PWS) and Schaaf-Yang (SYS) syndromes.

Funded Year:


Awarded to:

Larry Reiter, PhD




University of Tennessee Health Science Center


Larry Reiter, PhD

Search Projects

Donate for PWS Research